Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Australian Clinical Labs Ltd ( (AU:ACL) ) just unveiled an announcement.
Australian Clinical Labs Limited has announced the appointment of Ms. Sarah Butler and Mr. Grant Jeffery as non-executive directors, bringing extensive experience from diverse industries such as health, insurance, aerospace, and technology. Additionally, Mr. Matthew Cordingley will commence his role as the new Chief Financial Officer, starting 3 February 2025, which is expected to strengthen the company’s executive team and enhance its strategic positioning in the pathology services market.
More about Australian Clinical Labs Ltd
Australian Clinical Labs is a leading provider of pathology services across Australia, committed to excellence in medical testing and diagnostics. With state-of-the-art laboratories and a team of experienced professionals, ACL offers a comprehensive range of services to hospitals, medical specialists, and general practitioners.
YTD Price Performance: 6.40%
Average Trading Volume: 568,575
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$734.1M
For a thorough assessment of ACL stock, go to TipRanks’ Stock Analysis page.
